Brief: Harrow Licenses Canadian Rights To Apotex For Five Branded Ophthalmic Pharmaceutical Products
15/02/2024 21:03
Feb 15 (Reuters) - Harrow Inc HROW.O :
* HARROW LICENSES CANADIAN RIGHTS TO APOTEX FOR FIVE BRANDED
OPHTHALMIC PHARMACEUTICAL PRODUCTS
* HARROW INC - EXCLUSIVE OUT-LICENSING AGREEMENT UNDER WHICH
APOTEX WILL MARKET AND DISTRIBUTE VERKAZIA® AND OTC CATIONORM
PLUS IN CANADIAN MARKET
Source text for Eikon: ID:nBw9t4FNLa
Further company coverage: HROW.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates